110
Participants
Start Date
November 17, 2021
Primary Completion Date
February 5, 2024
Study Completion Date
February 5, 2024
Etonogestrel (ETG) implant
Contraceptive progestin implants are thin rods inserted under the skin of a woman's arm. The most widely available implant in South Africa is currently Implanon®/Nexplanon®/Implanon NXT®, containing etonogestrel (ETG, 3-keto desogestrel). Implanon® consists of a single rod of ethylene vinyl acetate and contains 68 mg of ETG; it is manufactured by Merck and is approved for 3 years.
Intramuscular depo-medroxyprogesterone acetate (IM DMPA)
DMPA (150 mg of depo-medroxyprogesterone acetate (MPA)/ml IMI) is the most commonly used injectable contraceptive worldwide, and the most commonly used method of reversible injectable contraception in sub-Saharan Africa.
Sub-cutaneous medroxyprogesterone acetate (SC MPA)
SC MPA or Sayana® Press is a single-dose container with 104 mg medroxyprogesterone acetate (MPA) in 0.65 mL suspension for injection. Sayana® Press is indicated for medium-long term female contraception.
Non-hormonal intrauterine device (IUD)
The NOVA T-380 non-hormonal IUD consists of a T-shaped polyethylene frame wound with copper wire, along with two monofilament threads to aid in removal of the IUD. IUDs may be left in place for up to 5 years.
Wits Reproductive Health and HIV Institute, Research Centre Clinical Research Site, Johannesburg
Merck Sharp & Dohme LLC
INDUSTRY
Wits Reproductive Health and HIV Institute
OTHER
University of Washington
OTHER
University of Alabama at Birmingham
OTHER